T. Rowe Price Associates
SHC icon

T. Rowe Price Associates’s Sotera Health SHC Stock Holding History

T. Rowe Price Associates’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Buy
212,752
+53,314
+33% +$885K ﹤0.01% 1639
2025
Q4 		$2.81M Buy
159,438
+42,176
+36% +$698K ﹤0.01% 1608
2025
Q3 		$1.84M Buy
117,262
+16,736
+17% +$235K ﹤0.01% 1766
2025
Q2 		$1.12M Buy
100,526
+2,948
+3% +$34.5K ﹤0.01% 1941
2025
Q1 		$1.14M Buy
97,578
+7,910
+9% +$102K ﹤0.01% 1889
2024
Q4 		$1.23M Buy
89,668
+15,156
+20% +$220K ﹤0.01% 1882
2024
Q3 		$1.25M Buy
74,512
+12,458
+20% +$182K ﹤0.01% 1879
2024
Q2 		$737K Buy
62,054
+2,574
+4% +$29.4K ﹤0.01% 2024
2024
Q1 		$715K Buy
59,480
+12,195
+26% +$181K ﹤0.01% 2058
2023
Q4 		$797K Buy
47,285
+2,522
+6% +$35.7K ﹤0.01% 1973
2023
Q3 		$671K Buy
44,763
+1,354
+3% +$22.8K ﹤0.01% 1974
2023
Q2 		$818K Sell
43,409
-231
-0.5% -$3.67K ﹤0.01% 1900
2023
Q1 		$782K Buy
43,640
+18,042
+70% +$301K ﹤0.01% 1904
2022
Q4 		$213K Buy
25,598
+4,614
+22% +$34.4K ﹤0.01% 2505
2022
Q3 		$144K Buy
20,984
+8,028
+62% +$133K ﹤0.01% 2636
2022
Q2 		$254K Buy
+12,956
New +$271K ﹤0.01% 2513

Other funds holding SHC

DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates's SHC Position: Q1 2026 in Review

T. Rowe Price Associates increased its Sotera Health (SHC) stake by 33% in Q1 2026, buying an estimated $885K and bringing the position to 212,752 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

T. Rowe Price Associates first reported a position in SHC in Q2 2022 and has held it in 16 quarters since. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • T. Rowe Price Associates held 212,752 shares of Sotera Health worth $3.05M as of Q1 2026.
  • T. Rowe Price Associates bought 53,314 Sotera Health shares in Q1 2026, an estimated $885K.
  • Sotera Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1639 holding.
  • T. Rowe Price Associates first reported a position in Sotera Health in Q2 2022 and has held it in 16 quarters since.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.